Dana Farber Cancer Institute/Brigham & Women's — Boston, Massachusetts

Dana Farber Cancer Institute/Brigham & Women's is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute/Brigham & Women's has participated in 4 clinical trials.

Therapeutic areas: Acute Leukemia, Myelodysplasia, Chronic Myelogenous Leukemia (CML).

Sponsors: National Heart, Lung, and Blood Institute (NHLBI), Medical College of Wisconsin.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute/Brigham & Women's?

Dana Farber Cancer Institute/Brigham & Women's has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute/Brigham & Women's conducted?

Dana Farber Cancer Institute/Brigham & Women's has 4 clinical trials on record. Their work covers Acute Leukemia, Myelodysplasia, Chronic Myelogenous Leukemia (CML).

Is Dana Farber Cancer Institute/Brigham & Women's accredited by Crixeo Health?

Dana Farber Cancer Institute/Brigham & Women's has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute/Brigham & Women's?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.